secwatch.observer — SEC 8-K summary
======================================

Issuer:     Grace Therapeutics, Inc. (GRCE)
CIK:        0001444192
Form:       8-K
Filed at:   2023-10-11T23:59:59+00:00
Accession:  0000950170-23-052891
Event type: other
Sentiment:  neutral
Materiality: 0.15
Item codes: 5.07
LLM model:  deepseek-v4-flash:cloud@v2

Acasti Pharma shareholders elect directors, ratify auditor, approve exec comp at annual meeting
--------------------------------------------------------------------------------

- Five director nominees elected with >97% votes for each; non-votes ~1.27M.
- Ernst & Young LLP appointed as auditor with 97.65% votes for (3,982,999 for).
- Advisory vote on executive compensation approved with 97.24% votes for (2,730,102 for).
- Shareholder turnout 54.76% (4,078,661 votes of 7,448,033 outstanding shares).
- Meeting held Oct 10, 2023; proxy solicitation unopposed.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023052891/0000950170-23-052891-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1444192/000095017023052891/acst-20231010.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-052891

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer